A phosphine-catalyzed remote 1,7-addition of vinyl allenoates has been developed, providing a series of 1,3-dienes derivatives in high yields (up to 99%) and with good chemo-, regio-, and stereoselectivity. This reaction demonstrated that the introduction of vinyl in allenoates effectively extended reaction types of phosphine-catalyzed nucleophilic addition of allenoates, leading to concise synthesis of diene carboxylates. Notably, the enantioselective variant of this 1,7-addition can also be performed by chiral phosphine catalyst.
The first enantioselective sequential
phosphine-catalyzed (SPC
as abbreviation) mode for the formation of tetrahydroquinolines with
an ethynyl-substituted all-carbon quaternary stereogenic center is
reported. In this SPC process, a novel [4 + 2] annulation process
was devised employing α-substituted allenoates as C2 synthons
(α–β′, 1,2-dipole) for the first time. 3-Ethynyl-substituted
tetrahydroquinolines were readily prepared in good yields and high
enantioselectivities.
The first (3 + 2)/(3 + 2) sequential annulation of γ-vinyl
allenoates with alkylidenemalononitriles enabled by phosphine catalysis
has been reported. A broad range of structurally dense tetra- and
penta-substituted bicyclic[3,3,0]octene derivatives, containing a
quaternary center and three sequential stereogenic center, were synthesized
in good to excellent yields. In this approach, three new C–C
bonds are formed in one pot, and εC and αC of γ-vinyl
allenoate are two electrophilic centers, whereas its γC exhibits
nucleophilic reactivity.
A phosphine-catalyzed (3+2)/(2+3) sequential annulation involving a triple nucleophilic addition reaction of γ-vinyl allenoates was successfully developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.